Factor Seven Activating Protease (FSAP) levels during normal pregnancy and in women using oral contraceptives

Mariana S. Parahuleva; Hans Hölschermann; Ali Erdoğan; Eva Langanke; Isabella Prickartz; Behnoush Parviz; Ralf Weiskirchen; Harald Tillmanns; Sandip M. Kanse

doi:10.1016/j.thromres.2010.03.003

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2014

Factor VII activating protease (FSAP): A novel protective factor in liver fibrosis

Adoración Martínez‐Palacián, Sandip M. Kanse, Ralf Weiskirchen

Article2012

Circulating Factor VII Activating Protease (FSAP) Is Associated With Clinical Outcome in Acute Coronary Syndrome

Mariana S. Parahuleva, Hans Hölschermann, Daniel Zandt, Jörn Pons‐Kühnemann, Behnoush Parviz, Ralf Weiskirchen, Anne Staubitz, Harald Tillmanns, Ali Erdoğan, Sandip M. Kanse

Article2012

Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men

Erawan Borkham‐Kamphorst, Henning W. Zimmermann, Nikolaus Gaßler, Ute Bissels, Andreas Bosio, Frank Tacke, Ralf Weiskirchen, Sandip M. Kanse

Article1998

Hemostatic Effects of Oral Contraceptives in Women who Developed Deep-vein Thrombosis while Using Oral Contraceptives

Kitty W.M. Bloemenkamp, Frans M. Helmerhorst, Ted Koster, Rogier M. Bertina, Jan P. Vandenbroucke, Frits R. Rosendaal

Thrombosis and Haemostasis

Letter2007

Rapid genotyping of the G534E polymorphism (Marburg I) of the gene encoding the factor VII-activating protease (FSAP) by LightCycler PCR

Carmen G. Tag, Senait Mengsteab, Sandip M. Kanse, Ralf Weiskirchen